Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
302 participants
INTERVENTIONAL
2014-10-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RN624 In Adult Patients With Chronic Low Back Pain
NCT00584870
Effectiveness of Theramine on Chronic Back Pain
NCT01468025
Study Evaluating the Gastrointestinal Safety of PLA-695 Compared to Placebo and Naproxen
NCT00366262
The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain
NCT02268305
Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
NCT00692055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PF-06372865
Daily BID dosing for 4 weeks
PF-06372865
Dose level 1 daily dosing BID for 1 week followed by dose level 2 daily BID for 3 weeks
Placebo
Daily BID dosing for 4 weeks
Placebo
Placebo for PF-06372865 and placebo for naproxen daily
Naproxen
Daily BID dosing for 4 weeks
Naproxen
500 mg BID for 4 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PF-06372865
Dose level 1 daily dosing BID for 1 week followed by dose level 2 daily BID for 3 weeks
Placebo
Placebo for PF-06372865 and placebo for naproxen daily
Naproxen
500 mg BID for 4 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Agave Clinical Research, LLC
Mesa, Arizona, United States
Arizona Research Center, Inc.
Phoenix, Arizona, United States
Global Research
Anaheim, California, United States
Neuro-Pain Medical Center
Fresno, California, United States
Providence Clinical Research
North Hollywood, California, United States
Elite Clinical Trials, Incorporate
Wildomar, California, United States
Stamford Therapeutics Consortium
Stamford, Connecticut, United States
Avail Clinical Research, LLC
DeLand, Florida, United States
S&W Clinical Research
Fort Lauderdale, Florida, United States
Florida Research Network, LLC
Gainesville, Florida, United States
Broward Research Group
Hollywood, Florida, United States
Jacksonville Center for Clinical Research
Jacksonville, Florida, United States
Compass Research, LLC
Orlando, Florida, United States
Pines Clinical Research Inc.
Pembroke Pines, Florida, United States
Accord Clinical Research, LLC
Port Orange, Florida, United States
Arthritis & Rheumatic Care Center
South Miami, Florida, United States
Miami Research Associates
South Miami, Florida, United States
Better Health Clinical Research, Inc.
Atlanta, Georgia, United States
River Birch Research Alliance, LLC
Blue Ridge, Georgia, United States
Family Medicine center
Columbus, Georgia, United States
Columbus Regional Research Institute
Columbus, Georgia, United States
Drug Studies America
Marietta, Georgia, United States
Better Health Clinical Research, Inc./Georgia Pain & Spine Care, Inc.
Newnan, Georgia, United States
Better Health Clinical Research, Inc.
Newnan, Georgia, United States
Southeast Regional Research Group
Savannah, Georgia, United States
North Georgia Clinical Research
Woodstock, Georgia, United States
North Georgia Internal medicine
Woodstock, Georgia, United States
Chicago Anesthesia Associates
Chicago, Illinois, United States
Centex Studies, Inc
Lake Charles, Louisiana, United States
Boston Clinical Trials
Boston, Massachusetts, United States
ActivMed Practices & Research, Inc.
Methuen, Massachusetts, United States
CRC of Jackson
Jackson, Mississippi, United States
Physician's Surgery Center
Jackson, Mississippi, United States
Drug Trials America
Hartsdale, New York, United States
AAIR Research Center
Rochester, New York, United States
Wake Internal Medicine Consultants, Inc.
Raleigh, North Carolina, United States
Wake Research Associates, LLC
Raleigh, North Carolina, United States
The Center for Clinical Research
Winston-Salem, North Carolina, United States
Summit Research Network (Oregon), Inc.
Portland, Oregon, United States
Altoona Center for Clinical Research
Duncansville, Pennsylvania, United States
Omega Medical Research
Warwick, Rhode Island, United States
Clinical Trial Network
Houston, Texas, United States
Lee Medical Associates, PA
San Antonio, Texas, United States
Progressive Clinical Research
San Antonio, Texas, United States
National Clinical Research - Norfolk, Inc.
Norfolk, Virginia, United States
Summit Research Network (Seattle) LLC
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B7431006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.